Table 2.

Characteristics of the patients.

Patient Variable AssessedNo. Patients with Available Data
Age, median yrs (IQR)55 (43–63)294
Disease duration, median yrs (IQR)2.3 (0.7–5.1)294
Early RA (< 1 year), %(39)294
Female, %(70)282
Rheumatoid factor-positive, %(57)294
Anti-CCP-positive, %(54)185
Erosive on radiography, %(66)290
DMARD, %(99)282
Biologics, %(15)287
Oral corticosteroids, %(25)203
DAS28-CRP, median (IQR)2.2 (1.8–2.6)294
SDAI, median (IQR)3.9 (1.9–6.5)188
CDAI, median (IQR)3.1 (1.5–5.8)188
  • Anti-CCP: anti-cyclic citullinated peptide antibodies; IQR: interquartile range; SDAI: Simplified Disease Activity Index; CDAI: Clinical Disease Activity Index.